Colinz Labs (531210)
FAST GROWERScore breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹65.1 |
| Market Cap | ₹16.48 Cr |
| P/E Ratio | 12.16 |
| ROCE | 6.72% |
| ROE | 5.29% |
| Dividend Yield | 0% |
| Profit Growth | 60% |
| Debt/Equity | — |
| Sales Growth | -2.72% |
| 52-Week Range | ₹36.11 — ₹87.91 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹41.85 |
Colinz Labs trades with a P/E ratio of 12.16, ROCE of 6.72%, ROE of 5.29%, profit growth of 60%.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer